Masuzawa Koichi, Jesmin Subrina, Maeda Seiji, Kaji Yuichi, Oshika Tetsuro, Zaedi Sohel, Shimojo Nobutake, Yaji Naoko, Miyauchi Takashi, Goto Katsutoshi
Department of Pharmacology, Institute of Basic Medical Sciences, University of Tsukuba, Ibaraki, Japan.
Exp Biol Med (Maywood). 2006 Jun;231(6):1085-9.
The retinal ischemia-reperfusion model is used in the study of transient ischemia-related diseases, such as central retinal artery occlusion, angle-closure glaucoma, and others. There are two methods for experimentally producing an ischemia-reperfusion model in the rat retina: (i) the intraocular pressure is greatly raised by increasing the height of the infusion bottle connected with the needle in the anterior chamber; or (ii) the blood vessel that accompanies the optic nerve in retina is ligated. However, each method has some drawbacks. For example, in the first method, the needle must be fixed in the anterior chamber for 1 hr, thus, the technique is not stable and mechanical damage to ocular structures sometimes occurs. In the second method, because of the unavoidable involvement of the optic nerve, damage to the nerve induces retinal changes unrelated to ischemia. In this study, we injected endothelin (ET)-1 under the conjunctiva of the eyeball (subconjunctival injection), and evaluated whether a retinal ischemia-reperfusion model could be generated by this method, simply and noninvasively. We injected 4 x 10(-5) M ET-1 solution into the right eye of the rat and injected a control vehicle (artificial tears) into the left eye. From 5-60 mins after the injection, 50 mg/ml fluorescein isothiocyanate (FITC)-dextran was injected to the left ventricle of heart. Then, the retina was removed and flat mounted. We compared the perfusion conditions of the FITC-dextran to each retina in the right and left eye. There was a complete perfusion of FITC-dextran in the retinal main artery, vein, and the capillary vessels in all of the control eyes. However, perfusion could not be completely observed in the ET-1 injected eye from 5-35 mins after injection; afterwards, the flow was returned. This method of subconjunctival injection of ET-1 is, thus, a feasible technical option for producing a retinal ischemia-reperfusion model in rat.
视网膜缺血再灌注模型用于研究短暂性缺血相关疾病,如视网膜中央动脉阻塞、闭角型青光眼等。在大鼠视网膜上通过实验建立缺血再灌注模型有两种方法:(i)通过增加与前房内针头相连的输液瓶高度大幅提高眼压;或(ii)结扎视网膜中与视神经伴行的血管。然而,每种方法都有一些缺点。例如,在第一种方法中,针头必须在前房固定1小时,因此该技术不稳定,有时会对眼结构造成机械损伤。在第二种方法中,由于不可避免地涉及视神经,神经损伤会引起与缺血无关的视网膜变化。在本研究中,我们在眼球结膜下注射内皮素(ET)-1(结膜下注射),并评估通过这种方法能否简单、无创地建立视网膜缺血再灌注模型。我们将4×10(-5)M的ET-1溶液注入大鼠右眼,并将对照载体(人工泪液)注入左眼。在注射后5 - 60分钟,将50mg/ml异硫氰酸荧光素(FITC)-葡聚糖注入心脏左心室。然后,取出视网膜并平铺。我们比较了左右眼每个视网膜中FITC-葡聚糖的灌注情况。所有对照眼中,FITC-葡聚糖在视网膜主动脉、静脉和毛细血管中完全灌注。然而,在注射ET-1的眼中,注射后5 - 35分钟无法完全观察到灌注;之后,血流恢复。因此,结膜下注射ET-1这种方法是在大鼠中建立视网膜缺血再灌注模型的一种可行技术选择。